MediWound Ltd.
MDWD- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001593984
In the last 90 days, MediWound Ltd. insiders filed 1 open-market purchase and 2 sales; 78 institutions reported holding it in 13F filings for Q2 2026, worth $85.5M in total; ARK Invest is the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding MediWound Ltd. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 20 | 1 | 18 | −1 |
| Shares | 2.05M | 33.4K | 1.96M | −61.5K (−3.0%) |
| Value | $21.8M | $350.8K | $20.9M | −$622.7K (−2.9%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (1)
Institutions that held MediWound Ltd. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Yelin Lapidot Holdings Management Ltd. | 86,145 | $936.4K | 0.23% |
Sold out (2)
Institutions that held MediWound Ltd. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| AWM Investment Company, Inc. | 142,857 | $1.50M |
| UBS Group AG | 45 | $480 |
Not filed for Q3 2023 yet (1)
Institutions that held MediWound Ltd. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Cowen Prime Advisors LLC | 33,409 | $350.8K |